Allogene Therapeutics (ALLO) Earnings (2018 - 2026)
Allogene Therapeutics (ALLO) earnings from Mar 31, 2018 to Mar 31, 2026. The TTM Allogene Therapeutics (ALLO) earnings is -$174M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Allogene Therapeutics (ALLO) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -31.14% |
| 3 Years TTM | -21.60% |
| 5 Years TTM | -5.35% |
| All Time TTM | -4.54% |
Annual Earnings change of Allogene Therapeutics (ALLO)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$43M | -77.68% |
| 2025 | -$191M | -25.89% |
| 2024 | -$258M | -21.29% |
| 2023 | -$327M | -3.86% |
| 2022 | -$340M | +86.99% |
| 2021 | -$182M | -27.24% |
| 2020 | -$250M | +35.55% |
| 2019 | -$185M | +324.34% |
| 2018 | -$44M | N/A |
| 2017 | $0 | N/A |
Comparison Allogene Therapeutics (ALLO) five years earnings CAGR with competitors
Allogene Therapeutics (ALLO) five years earnings CAGR is -5.35%.